Related Experiment Video
Updated: Mar 28, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Bacteremia in Early Infancy: Etiology and Management
Joseph B Cantey1, Amanda C Farris2, Sarah M McCormick2
1Department of Pediatrics, Divisions of Infectious Diseases and Neonatal/Perinatal Medicine, Texas A&M Health Science Center College of Medicine, Baylor Scott & White Health, 1901 SW HK Dodgen Loop, Temple, TX, 76502, USA. JCantey@sw.org.
Abstract:
We reviewed the literature regarding bacteremia in early infancy (age ≤ 90 days). Bacteremia remains a major cause of morbidity and mortality in young infants. However, recent epidemiologic data suggest that the incidence of bacteremia is decreasing and the pathogens responsible for invasive disease are changing. These changes will impact the evaluation and management of young infants. We review the current epidemiology of community-acquired bacteremia in early infancy with particular emphasis on the causative agents, diagnostic evaluation, and empiric and definitive antimicrobial treatment.
Related Concept Videos
Development of the Oral Microbiota
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Human Microbiota
Viral Meningitis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

